Bryonamide B
CAS No. 5942-25-6
Bryonamide B( —— )
Catalog No. M37731 CAS No. 5942-25-6
Bryonamide B is a cucurbitane triterpene that can be extracted from Bryonia aspera.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 64 | In Stock |
|
| 2MG | 36 | In Stock |
|
| 5MG | 59 | In Stock |
|
| 10MG | 86 | In Stock |
|
| 25MG | 145 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBryonamide B
-
NoteResearch use only, not for human use.
-
Brief DescriptionBryonamide B is a cucurbitane triterpene that can be extracted from Bryonia aspera.
-
DescriptionBryonamide B is a cucurbitane-type triterpenoid isolated from Bryonia aspera.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5942-25-6
-
Formula Weight211.21
-
Molecular FormulaC10H13NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NCCO)(=O)C1=CC(OC)=C(O)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Shamim Sahranavard, et al. New cucurbitane-type triterpenoids from Bryonia aspera. Planta Med. 2010 Jul;76(10):1014-7.?
molnova catalog
related products
-
Linzagolix
Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.
-
Substance P (5-11)
Substance P (5-11), the C-terminal heptapeptide of Substance P (Substance P ), is a neuropeptide. Substance P (5-11) binds to NK-1 tachykinin receptor.
-
(S)-OSMI 3
(S)-OSMI 3 (Ent-OSMI-3) has anti-inflammatory and anti-tumour activity and can be used to study diabetes and neurodegenerative diseases.
Cart
sales@molnova.com